Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Focal adhesion proteins confer smooth muscle anoikis resistance and protection against aortic aneurysm and dissection
Zhenyuan Zhu, Mingjun Liu, Jianxin Wei, Deepa Suryanarayan, Parya Behzadi, Robert Edgar, Julie A. Phillippi, Cynthia St. Hilaire, Cristina Espinosa-Diez, Delphine Gomez
Zhenyuan Zhu, Mingjun Liu, Jianxin Wei, Deepa Suryanarayan, Parya Behzadi, Robert Edgar, Julie A. Phillippi, Cynthia St. Hilaire, Cristina Espinosa-Diez, Delphine Gomez
View: Text | PDF
Research Article Cell biology Vascular biology

Focal adhesion proteins confer smooth muscle anoikis resistance and protection against aortic aneurysm and dissection

  • Text
  • PDF
Abstract

Thoracic aortic aneurysm and dissection (TAAD) involves a progressive dilation of the aortic wall associated with degradation of the extracellular matrix (ECM), cystic medial degeneration, smooth muscle cell (SMC) dysfunction, and rarefaction. TAAD etiology and pathogenesis suggest that alteration of mechanical force propagation may contribute to SMC dysfunction. This study aims to determine the role of SMC focal adhesion proteins, which are key components of force transmission, in TAAD pathogenesis. scRNA-seq analysis of human TAA aortas showed reduced expression of intracellular focal adhesion components, including PTK2 (FAK), VCL, ILK, and TES transcripts, in SMCs. Additionally, protein levels of FAK, ILK, and VCL were decreased in the aorta of patients with TAA. SMC-specific Ptk2, Vcl, and Ilk KO mice treated with β-aminopropionitrile (BAPN) exhibited increased mortality, aortic dilation, ECM breakdown, and SMC loss. Mechanistically, knocking down FAK, ILK, and VCL exacerbated gliotoxin-induced SMC anoikis, whereas overexpressing full-length WT and dead-kinase FAK conferred resistance to apoptosis and cell detachment, indicating that FAK’s protective effects depend on its expression rather than its enzymatic activity. Inhibition of FAK kinase activity did not affect SMC apoptosis in vitro or aortic dilation in vivo. Our findings demonstrate that the expression of focal adhesion proteins protects against TAAD progression and SMC anoikis independently of FAK kinase activity.

Authors

Zhenyuan Zhu, Mingjun Liu, Jianxin Wei, Deepa Suryanarayan, Parya Behzadi, Robert Edgar, Julie A. Phillippi, Cynthia St. Hilaire, Cristina Espinosa-Diez, Delphine Gomez

×

Figure 8

FAK kinase activity inhibition does not prevent gliotoxin-induced anoikis and aneurysm formation.

Options: View larger image (or click on image) Download as PowerPoint
FAK kinase activity inhibition does not prevent gliotoxin-induced anoiki...
(A) Representative images showing levels of phospho-FAK (Y397) and total FAK in mouse SMC pretreated with a FAK inhibitor (Defactinib: 1 μM, 24 hours) or DMSO, prior to incubation with Gliotoxin or Vehicle for 6 hours. GAPDH was used as a loading control (repeated 3 times, independently). (B) Representative flow cytometry histograms of Annexin V–Alexa Fluor 647 staining. (C) Quantification of Annexin V+ cells. Student’s t test. (D) Schematic diagram representing in vivo FAK inhibition studies. Twenty-eight-day-old mice were treated with BAPN and DMSO or Defactinib (20 mg/kg/day) for 28 days. (E) Survival probability was unchanged in mice treated with DMSO or FAKi. Kaplan-Meier test. (F) Representative images of the aortas of mice receiving FAKi or DMSO. Scale bar: 1 mm. (G) Measurement of the maximal aortic diameter (mm). Student’s t test. (H) H&E staining of aortic cross-sections. Scale bar: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts